enGene Therapeutics ENGN Cash Flow Statement (2022-2026)

NASDAQ ENGN
$1.77 -0.08 (-4.32%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income (Quarter) -7.42M-5.28M-4.72M-82.50M-10.71M-14.98M-14.15M-15.30M-24.62M-25.82M-28.99M65.85M-29.75M-30.23M
Depreciation and Depletion (Quarter) 0.05M0.04M0.04M0.05M0.08M0.08M0.08M0.08M0.10M0.11M0.13M0.17M0.19M0.18M
Share-based Compensation (Quarter) 0.02M0.04M0.04M3.35M0.29M1.92M1.46M1.66M1.81M2.65M30.10M2.61M2.80M45.20M
Gains from Investment Securities (Quarter) 1.19M0.34M-5.52M-6.85M
Cash from Operations (Quarter) -6.22M-4.44M-7.30M-6.78M-7.37M-14.16M-7.18M-19.57M-25.70M-22.95M-25.63M-24.96M-28.90M-30.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.78M1.20M0.67M0.59M0.49M
Amortization of Deferred Charges (Quarter) 1.16M0.50M1.05M-1.93M0.16M0.21M0.22M0.22M0.21M0.21M0.22M0.21M0.18M0.14M
Depreciation & Amortization (CF) (Quarter) 0.05M0.04M0.04M0.07M0.08M0.10M0.10M0.10M0.10M0.10M0.10M0.20M0.19M0.20M
Change in Working Capital
Change in Account Payables (Quarter) 0.83M1.22M-1.08M-0.59M0.22M-0.91M2.61M-1.45M1.13M-0.97M0.82M3.97M-4.27M-0.62M
Change in Accured Expenses (Quarter) -1.82M-0.45M0.17M2.97M2.15M0.41M3.20M-0.54M-3.88M3.92M-1.06M4.15M4.39M-2.48M
Other Working Capital Changes (Quarter) 0.04M-0.00M-0.04M-0.04M-0.17M0.08M0.13M0.23M0.04M-0.28M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.01M0.16M0.14M0.51M0.18M0.00M0.24M0.30M0.04M0.70M-0.72M0.15M0.10M
Change in Acquisitions & Divestments (Quarter) 10.00M31.75M46.76M48.69M43.04M73.95M
Cash from Investing Activities (Quarter) -0.01M-0.01M-0.16M-0.14M-0.51M-0.18M-0.00M-125.27M-84.96M17.95M1.38M40.50M-126.30M23.64M
Financing Activities
Other financing activities (Quarter) 56.88M60.15M0.00M0.20M0.03M1.99M126.25M-125.97M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 30.00M22.50M25.00M
Change in Capital Stock
Shares Issued (Quarter) 1.58M2.71M3.29M3.98M2.47M6.03M9.07M9.05M9.41M9.03M12.08M3.93M
Misc.
Cash from Financing Activities (Quarter) -0.01M7.76M27.55M50.84M12.00M193.50M0.05M60.16M0.00M0.20M-0.67M1.99M141.66M0.07M
Exchange Rate Effect (Quarter) 0.00M0.00M0.00M0.00M
Change in Cash (Quarter) -6.25M3.31M20.10M43.93M4.12M179.16M-7.13M-84.67M-110.66M-4.80M-24.92M17.53M-13.54M-6.79M
Free Cash Flow (Quarter) -6.24M-4.45M-7.46M-6.91M-7.88M-14.34M-7.18M-19.81M-26.00M-22.99M-26.34M-24.25M-29.05M-30.60M
Net Cash Flow (Quarter) -6.25M3.31M20.10M43.93M4.12M179.16M-7.13M-84.67M-110.66M-4.80M-24.92M17.53M-13.54M-6.79M